Genitourinary Radiology: Page 7

Delayed SPECT improves prostate cancer detection

By Will Morton

Delaying SPECT/CT imaging by 15 hours after radiotracer injection can enable the identification of more tumors in patients with relapsed prostate cancer, according to a study published May 25 in the Journal of Nuclear Medicine.

May 25, 2023

PSMA-PET/CT is cost-effective over standard prostate cancer imaging

By Will Morton

A cost analysis has demonstrated that prostate-specific membrane antigen (PSMA)-PET/CT imaging with F-18 DCFPyL radiotracer should be considered as an alternative to standard imaging for prostate cancer staging, according to a group in New York.

May 24, 2023

SPECT reduces kidney imaging times in children

By Will Morton

Shorter scan times of five minutes during kidney imaging in children are feasible using newer SPECT cameras with cadmium-zinc-telluride (CZT) detectors, according to a study published May 15 in Pediatric Radiology.

May 17, 2023

X-ray reveals gigantic bladder stones

By Will Morton

The authors of a case they dubbed "the Andes of bladder stones" described finding gigantic phosphate stones on a 60-year-old man's abdominal x-ray in a study published in Urology Case Reports.

May 11, 2023

Ricoh secures expanded FDA clearance for anatomic soft tissue models

By AuntMinnie.com staff writers

Ricoh 3D for Healthcare has received expanded clearance from the U.S. Food and Drug Administration (FDA) for its 3D-printed diagnostic anatomic models for cardiovascular, neurological, gastrointestinal, genitourinary, and breast applications.

May 4, 2023

Curasight joins forces with Curium

By AuntMinnie.com staff writers

Danish theranostics technology developer Curasight has formed a global partnership with nuclear medicine firm Curium to support the development of its uTrace radiopharmaceutical for use in prostate cancer.

May 2, 2023

Is biopsy needed prior to PSMA-PET in elderly patients?

By Philip Ward

Prostate cancer PET/CT imaging can potentially obviate the need for invasive biopsies in elderly patients before they begin therapy, according to a study published April 28 in the Journal of Nuclear Medicine.

May 1, 2023

Blue Earth touts clinical results

By AuntMinnie.com staff writers

Blue Earth Diagnostics is highlighting results from a clinical study that has investigated the efficacy of the PET imaging agent F-18 rhPSMA-7.3 for detecting recurrent prostate cancer.

April 30, 2023

Avenda reaches milestone with Unfold AI software

By AuntMinnie.com staff writers

Artificial intelligence (AI) software developer Avenda Health said that its Unfold AI prostate cancer management platform has been used for the first time in a commercial setting.

April 27, 2023

Use of both iodine- and gado-based contrast boosts kidney injury risk

By Kate Madden Yee

Patients who present in the emergency department (ED) and undergo advanced CT and MR imaging with both iodine- and gadolinium-based contrast are at higher risk of postcontrast acute kidney injury (PC-AKI).

April 27, 2023

AUA, SUO issue guideline for prostate cancer detection

By AuntMinnie.com staff writers

The American Urological Association (AUO) and the Society of Urologic Oncology (SUO) have issued a 2023 clinical practice guideline on the early detection of prostate cancer.

April 25, 2023

New MRI technique helps target ultrasound-guided prostate biopsy

By Kate Madden Yee

A new microstructure imaging technique, hybrid multidimensional MRI (HM-MRI), could enable better targeting of areas in the prostate that need to be biopsied, according to a presentation at the American Roentgen Ray Society annual meeting in Honolulu.

April 23, 2023

Previous Page

Page 7 of 93

Next Page